HLS vs NXN

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

49LOW

NXN

NEXSEN LTD FPO [NXN]

49LOW

Score Breakdown

HLS NXN
Technical
50
75
Catalyst
61
53
Sentiment
50
50
Fundamental
91
72
Momentum
37
44
Risk Gate
32
42

Key Metrics

HLS Metric NXN
$415.3MMarket Cap$34.0M
3.5MAvg Volume (20d)361K
+6.3%Short InterestN/A
$1.63552-Week High$0.315
$0.55752-Week Low$0.130
-0.5%Daily Change+15.2%
$0.572Entry Price$0.190
-69.3%ROEN/A
-12.3%Profit MarginN/A

Active Signals

HLS Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.3x)
EPS estimates revised upward (+10pts)
Near 52-week low (1% of range)

NXN Signals

MACD momentum is picking up steam
Pressing against the upper Bollinger Band — extended and may need to cool off
Volume surging at 3.0x normal while price climbs — real buying conviction behind this move
Knocking on the door of resistance — if it punches through, things could get interesting
On a tear — up 18.8% over the last 5 days
Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
Volatility is expanding fast — choppy price action, so buckle up
Adequate cash runway (8 quarters)

Ask Scout AI to compare HLS and NXN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
HLS Full Analysis → NXN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).